L’hypothyroïdie est le trouble thyroïdien le plus fréquent. Existe-t-il des recommandations nutritionnelles pour limiter ses effets ?
Compléments alimentaires
La berbérine est un principe actif utilisé depuis plus de 2500 ans dans la pharmacopée traditionnelle ayurvédique et chinoise. En phytothérapie, elle est réputée pour son action hypoglycémiante mais elle possède de nombreuses autres propriétés thérapeutiques reconnues scientifiquement.
La berbérine est un alcaloïde végétal issu majoritairement de plantes du genre Berberis, comme l’épine-vinette, Berberis vulgaris. De la famille des berbéridacées, l’épine-vinette est un arbuste épineux pouvant atteindre 2 mètres de haut. La berbérine est retrouvée également dans d’autres plantes...
Références
- Guo J, Chen H, Zhang X et al. (2021). The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxid Med Cell Longev. 2021:2074610.
- He Q, Dong H, Guo Y et al. (2022). Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus. Front Endocrinol (Lausanne). 13:1074348.
- Pirillo A, Catapano AL (2015). Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies. Atherosclerosis. 243(2):449-61.
- Shou JW, Shaw PC (2023). Berberine Reduces Lipid Accumulation in Obesity via Mediating Transcriptional Function of PPARδ. Int J Mol Sci. 24(14):11600.
- Rui R, Yang H, Liu Y et al. (2021). Effects of Berberine on Atherosclerosis. Front Pharmacol. 12:764175.
- Hu Y, Davies GE (2009). Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation. Phytomedicine. 16(9):864-73.
- Hu Y, Davies GE (2010). Berberine inhibits adipogenesis in high-fat diet-induced obesity mice. Fitoterapia. 81(5):358-66.
- Meng S, Wang LS, Huang ZQ et al. (2012). Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention. Clin Exp Pharmacol Physiol. 39(5):406-11.
- Lu Q, Fu Y, Li H (2022). Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders. Pharmacol Rep. 74(2):297-309.
- Sarbadhikary P, George BP, Abrahamse H (2021). Inhibitory Role of Berberine, an Isoquinoline Alkaloid, on NLRP3 Inflammasome Activation for the Treatment of Inflammatory Diseases. Molecules. 26(20):6238.
- Domitrović R, Jakovac H, Blagojević G (2011). Hepatoprotective activity of berberine is mediated by inhibition of TNF-α, COX-2, and iNOS expression in CCl(4)-intoxicated mice. Toxicology. 280(1-2):33-43.
- Reddi KK, Li H, Li W, Tetali SD (2021). Berberine, A Phytoalkaloid, Inhibits Inflammatory Response Induced by LPS through NF-Kappaβ Pathway: Possible Involvement of the IKKα. Molecules. 26(16):4733.
- Enkhtaivan G, Muthuraman P, Kim DH et al. (2017). Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase. Bioorg Med Chem. 25(20):5185-5193.
- Wang ZZ, Li K, Maskey AR et al. (2021). A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study. FASEB J. 35(4):e21360.
- Chen S, Shen W, Liu Y et al. (2023). Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial. Chin Med J (Engl). 136(14):1690-1698.
- Zorić N, Kosalec I, Tomić S et al. (2017). Membrane of Candida albicans as a target of berberine. BMC Complement Altern Med. 17(1):268.
- Botwina P, Owczarek K, Rajfur Z et al. (2020). Berberine Hampers Influenza A Replication through Inhibition of MAPK/ERK Pathway. Viruses. 12(3):344.
- Xiong RG, Huang SY, Wu SX et al. (2022). Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review. Molecules. 27(14):4523.
- Hu S, Zhao R, Liu Y et al. (2019). Preventive and Therapeutic Roles of Berberine in Gastrointestinal Cancers. Biomed Res Int. 2019:6831520.
- Vlavcheski F, O'Neill EJ, Gagacev F, Tsiani E (2022). Effects of Berberine against Pancreatitis and Pancreatic Cancer. Molecules. 27(23):8630.
- Gasmi A, Asghar F, Zafar S et al. (2024). Berberine: Pharmacological Features in Health, Disease and Aging. Curr Med Chem. 31(10):1214-1234.
- Wei W, Yao JX, Zhang TT et al. (2023). Network pharmacology reveals that Berberine may function against Alzheimer's disease via the AKT signaling pathway. Front Neurosci. 17:1059496.
- Sahu K, Singh S, Devi B et al. (2022). A Review on the Neuroprotective Effect of Berberine against Chemotherapy- induced Cognitive Impairment. Curr Drug Targets. 23(9):913-923.
- Luo D, Yu B, Sun S et al. (2023). Effects of adjuvant berberine therapy on acute ischemic stroke: A meta-analysis. Phytother Res. 37(9):3820-3838.
- Zhu X, Guo X, Mao G et al. (2013). Hepatoprotection of berberine against hydrogen peroxide-induced apoptosis by upregulation of Sirtuin 1. Phytother Res. 27(3):417-21.
- Shen P, Jiao Y, Miao L et al. (2020). Immunomodulatory effects of berberine on the inflamed joint reveal new therapeutic targets for rheumatoid arthritis management. J Cell Mol Med. 24(21):12234-12245.
Cet article est réservé aux abonnés
Déjà abonné ?
Retrouvez la suite de votre article en vous connectant à votre espace personnel.
Je m'identifie
Pas encore abonné ?
Accédez à des articles et conseils exclusifs en vous abonnant pour seulement 39 € / an.
Je m'abonne Publicité
